All‐cause and cardiorenal mortality in 6 million adults with and without type 2 diabetes: A comparative, trend analysis in Canada, Spain, and the UK

Author:

Ling Suping123ORCID,Zaccardi Francesco12,Vlacho Bogdan4ORCID,Li Ping5,Real Gatius Jordi6,Mata‐Cases Manel46ORCID,Franch‐Nadal Josep46,Kosiborod Mikhail N.78ORCID,Gillies Clare12,Fenici Peter9101112,Mauricio Dídac461314ORCID,Shah Baiju R.51516ORCID,Khunti Kamlesh12ORCID

Affiliation:

1. Leicester Diabetes Research Centre University Hospital Leicester, Leicester General Hospital Leicester UK

2. Leicester Real World Evidence Unit, Diabetes Research Centre University of Leicester Leicester UK

3. Department of Non‐communicable Disease Epidemiology, Faculty of Epidemiology & Population Health The London School of Hygiene & Tropical Medicine London UK

4. DAP‐Cat group, Unitat de Suport a la Recerca Barcelona Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) Barcelona Spain

5. Institute for Clinical Evaluative Sciences (ICES) Burnaby Canada

6. CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM) Instituto de Salud Carlos III (ISCIII) Barcelona Spain

7. Saint Luke's Mid America Heart Institute Kansas City Missouri USA

8. University of Missouri Kansas City Missouri USA

9. AstraZeneca Cambridge UK

10. Medical Innovation, AstraZeneca SpA Milan Italy

11. Catholic University, School of Medicine and Surgery Rome Italy

12. Biomagnetism and Clinical Physiology International Center (BACPIC) Rome Italy

13. Department of Medicine University of Vic ‐ Central University of Catalonia Vic Spain

14. Department of Endocrinology and Nutrition Hospital Universitari de la Santa Creu i Sant Pau Barcelona Spain

15. Department of Medicine University of Toronto Toronto Ontario Canada

16. Department of Medicine Sunnybrook Health Sciences Centre Toronto Ontario Canada

Funder

AstraZeneca

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3